EXICURE INC
For the period ended Sep 30, 2024. Filed Nov 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 14, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Statements of Cash Flows
(in thousands)
| Nine Months Ended September 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash flows from operating activities: | ||
| Net loss | $(2,520) | $(15,427) |
| Adjustments to reconcile net loss to cash used in operating activities: | ||
| Depreciation and amortization | 21 | 627 |
| Equity-based compensation | 16 | 1,327 |
| Amortization of right-of-use asset | 591 | 551 |
| Changes in fair value of investment in convertible notes receivable | — | 2,000 |
| Loss from sale of property and equipment | — | 920 |
| Changes in operating assets and liabilities: | ||
| Other receivable | (1,335) | — |
| Prepaid expenses and other current assets | 607 | 124 |
| Other noncurrent assets | — | 291 |
| Accounts payable | (293) | 504 |
| Accrued expenses | 1,457 | 78 |
| Other liabilities | (609) | (536) |
| Net cash used in operating activities | (2,065) | (9,541) |
| Cash flows from investing activities: | ||
| Purchase of available-for-sale securities | — | (2,000) |
| Proceeds from sale of property and equipment | — | 211 |
| Net cash used in investing activities | — | (1,789) |
| Cash flows from financing activities: | ||
| Proceeds from short-term borrowing | 1,000 | — |
| Proceeds from common stock offering | — | 5,440 |
| Payment of common stock financing costs | — | (843) |
| Payment of exercise of common stock warrants | — | (800) |
| Payments for minimum statutory tax withholding related to net share settlement of equity awards | — | (122) |
| Net cash provided by provided by financing activities | 1,000 | 3,675 |
| Net (decrease) in cash, cash equivalents, and restricted cash | (1,065) | (7,655) |
| Cash, cash equivalents, and restricted cash - beginning of period | 2,016 | 9,777 |
| Cash, cash equivalents, and restricted cash - end of period | $951 | $2,122 |
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)
(in thousands)
| Nine Months Ended September 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Supplemental disclosure of cash flow information | ||
| Non-cash investing activities: | ||
| Other receivable from sale of property and equipment | $— | $711 |
| Non-cash financing activities: | ||
| Equity effect of debt to equity conversion | $1,018 | $— |
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the unaudited condensed consolidated balance sheets that sum to the total of the amounts shown in the unaudited condensed consolidated statements of cash flows:
| September 30,2024 | December 31,2023 | |
|---|---|---|
| Cash and cash equivalents | $343 | $816 |
| Restricted cash included in other noncurrent assets | 608 | 1,200 |
| Total cash, cash equivalents, and restricted cash shown in the unaudited condensed consolidated statements of cash flows | $951 | $2,016 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.